Literature DB >> 21543582

Upgraded Cobas Ampliprep-Cobas TaqMan version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations.

M Wirden1, R Tubiana, S Fourati, M Thevenin, A Simon, A Canestri, Z Ait-Arkoub, C Soulie, A G Marcelin, C Katlama, V Calvez.   

Abstract

The large underestimations of HIV RNA quantification observed in 17 patients with the first version of Cobas TaqMan assay have been successfully corrected in the upgraded version 2.0. In comparison with the Abbott RealTime assay, the mean difference that was 1.18 log(10) copies/ml is now zero. The discrepancies have disappeared.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21543582      PMCID： PMC3147878          DOI： 10.1128/JCM.00061-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays.

Authors:  Jean-Marie Sire; Muriel Vray; Mourad Merzouk; Jean-Christophe Plantier; Juliette Pavie; Sarah Maylin; Julie Timsit; Caroline Lascoux-Combe; Jean-Michel Molina; François Simon; Constance Delaugerre
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

2.  Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes.

Authors:  Marie Gueudin; Jean Christophe Plantier; Véronique Lemée; Marie Paule Schmitt; Loic Chartier; Thomas Bourlet; Annick Ruffault; Florence Damond; Muriel Vray; François Simon
Journal:  J Acquir Immune Defic Syndr       Date:  2007-04-15       Impact factor: 3.731

3.  Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine.

Authors:  Patrick Braun; Robert Ehret; Frank Wiesmann; Frauke Zabbai; Mechthild Knickmann; Rainer Kühn; Sven Thamm; Gerald Warnat; Heribert Knechten
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

4.  Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.

Authors:  M Wirden; R Tubiana; F Marguet; I Leroy; A Simon; M Bonmarchand; Z Ait-Arkoub; R Murphy; A G Marcelin; C Katlama; V Calvez
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

5.  Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections.

Authors:  Deirdre Church; Daniel Gregson; Tracie Lloyd; Marina Klein; Brenda Beckthold; Kevin Laupland; M John Gill
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

6.  Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

Authors:  Melanie A Thompson; Judith A Aberg; Pedro Cahn; Julio S G Montaner; Giuliano Rizzardini; Amalio Telenti; José M Gatell; Huldrych F Günthard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; Peter Reiss; Douglas D Richman; Paul A Volberding; Patrick Yeni; Robert T Schooley
Journal:  JAMA       Date:  2010-07-21       Impact factor: 56.272

7.  Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants.

Authors:  Africa Holguín; Marisa López; Mar Molinero; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2008-07-02       Impact factor: 5.948

8.  Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient.

Authors:  Constance Delaugerre; Blandine Denis; Gilles Peytavin; Pierre Palmer; Thomas Mourez; Jerôme Le Goff; Jean-Michel Molina; François Simon
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948
  8 in total
  3 in total

1.  Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration.

Authors:  Luke C Swenson; Bryan Cobb; Anna Maria Geretti; P Richard Harrigan; Mario Poljak; Carole Seguin-Devaux; Chris Verhofstede; Marc Wirden; Alessandra Amendola; Jurg Boni; Thomas Bourlet; Jon B Huder; Jean-Claude Karasi; Snjezana Zidovec Lepej; Maja M Lunar; Odette Mukabayire; Rob Schuurman; Janez Tomazic; Kristel Van Laethem; Linos Vandekerckhove; Annemarie M J Wensing
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

2.  Evaluation of the Aptima HIV-1 Quant Dx Assay Using Plasma and Dried Blood Spots.

Authors:  Malaya K Sahoo; Vici Varghese; Elizabeth White; Meg Winslow; David A Katzenstein; Robert W Shafer; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2016-08-17       Impact factor: 5.948

3.  Technical and regulatory shortcomings of the TaqMan version 1 HIV viral load assay.

Authors:  Chanson J Brumme; Luke C Swenson; Brian Wynhoven; Benita Yip; Stuart Skinner; Viviane Dias Lima; Julio S G Montaner; P Richard Harrigan
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.